Clinicoradiologic Relationships in Case of Grave's Orbitopathy

Cover Page

Abstract


Purpose. To evaluate the relationship of clinical and radiologic findings in improving of diagnostics and amendment of the outcome.Material and methods. 52 patients (104 orbial cavities) in the age of 18–61 years were examined. Patients with the clinical symptoms of Grave’s orbitopathy were examined using ophthalmological evaluation and MSCT-visualization of orbial cavities.Results. The most significant MSCT-parameters for the determination of severity are: prolapse of orbital fat (р = 0.0009), protrusion of eye bulb (р = 0.001), apical inspissations (р = 0.019), density of RBCmin (р = 0.004), size of external terminal membrane (р = 0.001), size of LRM (р = 0.002), size of MRM (р = 0.006), length of optic nerve (р = 0.0001), diameter of optic nerve in 1 cm from the macula (р = 0.01), width of lacrimal gland (р = 0.0002).Conclusions. There is significant relationship between clinical and radiologic (MSCT) features. It lets develop the protocolof examination for diagnostics and treatment of Grave’s orbitopathy.

About the authors

Email: natsvir@nm.ru

References

  1. Бровкина А.Ф. Эндокринная офтальмопатия М.: ГЕОТАР-МЕД, 2004. 176 с.
  2. Шамшинова А.М., Бровкина А.Ф., Пантелеева О.Г. др. Функциональные симптомы поражения зрительной системы при эндокринной офтальмопатии. // Матер. VIII Моск. науч.практ. нейроофтальмолог. конф. “Актуальные вопросы нейроофтальмологии”. М. 2004. С. 37–38.
  3. Bartalena L., Pinchera A., Marcocci C. Management of Graves’ ophthalmopathy: reality and perspectives // Endocr. Rev. 2000. V. 21. P. 168–199.
  4. Bahn R.S., Gorman C.A. Choice of therapy and criteria for assessing treatment outcome in thyroid-associated ophthalmopathy // Endocr. Met. Clin. N. Am. 1987. V. 16. P. 391–407.
  5. Dickinson A.J., Perros P. Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative phothographs for objective assessment // Clin. Endocr. 2001. V. 55. P. 283–303.
  6. Firbann M., Culthard A. Evaluation of technique for estimation of extraocular muscle // Br. J. Radiol. 2000. V. 13. P. 1282–1289.
  7. Perros P., Dickinson AJ. Ophthalmopathy. In Werner’s and Ingbar’s The Thyroid – A Fundamental and Clinical Text, edn. 9, ch. 23B / Eds. L.E. Braverman, R.D. Utiger. Philadelphia: Lippincott Williams & Wilkins. 2005. P. 474–487.
  8. Rundie F.F. Development and course of exophthalmos and ophthalmoplegia in Graves’ diseasee with special reference to the effect of thyroidectomy // Clin. Sci. 1945. V. 5. P. 177–194.
  9. Mourits M.P., Koornneef L., Wiersinga W.M. et al. Clinical criteria for the assessment of disease activity in Graves’ ophthalmopathy: a novel approach // Brit. J. Ophthalmol. 1989. V. 73. P. 639–644.
  10. Mourits M.P., Prummel M.F., Wiersinga W.M., Koornneef L. Clinical activity score as a guide in the management of patients with Graves’ ophthalmopathy // Clin. Endocrinol. (Oxford).1997. V. 47. P. 9–14.
  11. Wiersinga W.M., Kahaly G.J. Graves’ orbitopathy. A multidisciplinary approach // Basel (Switzerland). 2007. P. 1–23.
  12. Wiersinga W.M., Prummer M.F. An evidence-based approach to the treatment Graves’ ophthalmopathy // Endocr. Met. Clin. N. Am. 2000. V. 29. N 2. P. 297–319.
  13. Wiersinga W.M., Perros P., Kahaly G.J. et al. Clinical assessment of patients with Graves’orbitopathy: the European Group on Graves’ Orbitopathy recommendations to generalists, specialists and clinical researchers // Eur. J. Endocr. 2006. V. 155. P. 387–389.
  14. Werner S.C. Modification of the classification of the eye changes of Graves’ disease // Am. J. Ophthalmol. 1977. V. 83. P. 725–727.

Statistics

Views

Abstract - 738

PDF (Russian) - 511

Cited-By


PlumX

Dimensions


Copyright (c) 2009 ., ., ., ., ., ., .

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies